These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31798701)

  • 1. Schisandrin B attenuates pressure overload-induced cardiac remodeling in mice by inhibiting the MAPK signaling pathway.
    Ai F; Guo QH; Yu B; Li W; Guo X; Chen Z
    Exp Ther Med; 2019 Dec; 18(6):4645-4652. PubMed ID: 31798701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
    Chen DD; Dong YG; Liu D; He JG
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
    Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
    Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
    Beckles DL; Mascareno E; Siddiqui MA
    Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17beta-estradiol attenuates the development of pressure-overload hypertrophy.
    van Eickels M; Grohé C; Cleutjens JP; Janssen BJ; Wellens HJ; Doevendans PA
    Circulation; 2001 Sep; 104(12):1419-23. PubMed ID: 11560859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beneficial effects of Schisandrin B on the cardiac structure and function in a mice model of myocardial infarction].
    Chen PS; Liu J; Meng HY; Wu P; Yang ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Nov; 45(11):963-970. PubMed ID: 29166724
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
    Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
    Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The regulatory mechanism of Raf/MEK/ERK pathway on the rat cardiac hypertrophy induced by transverse aortic constriction].
    Fu DT; Tu J; Cai YQ; Cai ZW; Zhang LZ; Liu JY; Xu SC; Wang DJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):33-38. PubMed ID: 32476371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
    Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
    Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt/β-catenin signaling pathway.
    Li Q; Jiang W; Wan Z; Ni Y; Lei L; Wei J
    Life Sci; 2020 Jul; 252():117624. PubMed ID: 32259602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
    Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
    Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide contributes to the attenuation of cardiac hypertrophy by suppressing endoplasmic reticulum stress.
    Tian Q; Liu J; Chen Q; Zhang M
    Pharm Biol; 2023 Dec; 61(1):61-68. PubMed ID: 36548192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
    Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
    Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin Reduces Cardiac Interstitial Fibrosis by Inhibiting Erk1/2-Serpine2 and P-Akt Signalling Pathways.
    Li X; Wang G; QiLi M; Liang H; Li T; E X; Feng Y; Zhang Y; Liu X; Qian M; Xu B; Shen Z; Gitau SC; Zhao D; Shan H
    Cell Physiol Biochem; 2018; 45(5):1955-1965. PubMed ID: 29518782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-β/Smads and MAPKs signaling activated fibrosis.
    Chen H; Song H; Liu X; Tian J; Tang W; Cao T; Zhao P; Zhang C; Guo W; Xu M; Lu R
    Biomed Pharmacother; 2017 Nov; 95():461-468. PubMed ID: 28865366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.